HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mikako Ogawa Selected Research

silicon phthalocyanine

10/2021Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy.
1/2020Surface Modification of Liposomes Using IR700 Enables Efficient Controlled Contents Release Triggered by Near-IR Light.
1/2020Theoretical and Experimental Studies on the Near-Infrared Photoreaction Mechanism of a Silicon Phthalocyanine Photoimmunotherapy Dye: Photoinduced Hydrolysis by Radical Anion Generation.
11/2018Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mikako Ogawa Research Topics

Disease

47Neoplasms (Cancer)
05/2022 - 01/2003
10Atherosclerotic Plaque (Atheroma)
11/2021 - 09/2004
7Neoplasm Metastasis (Metastasis)
03/2015 - 01/2003
5Atherosclerosis
01/2019 - 10/2008
5Ovarian Neoplasms (Ovarian Cancer)
03/2015 - 08/2008
4Hypoxia (Hypoxemia)
05/2022 - 01/2014
4Alzheimer Disease (Alzheimer's Disease)
10/2013 - 02/2006
3Inflammation (Inflammations)
01/2017 - 11/2006
2Lymphedema (Milroy Disease)
07/2020 - 12/2009
2Melanoma (Melanoma, Malignant)
03/2020 - 06/2009
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 01/2013
1Blister (Bulla)
11/2021
1Edema (Dropsy)
10/2021
1Burns
02/2021
1Cholangiocarcinoma
02/2021
1Fibrosis (Cirrhosis)
07/2020
1Disease Progression
07/2020
1Rupture
01/2020
1Carcinoma (Carcinomatosis)
01/2020
1Embolism (Embolus)
01/2019
1Lung Neoplasms (Lung Cancer)
09/2016
1Neuroinflammatory Diseases
05/2015
1Brain Neoplasms (Brain Tumor)
05/2015
1Ischemia
05/2015

Drug/Important Bio-Agent (IBA)

8Monoclonal AntibodiesIBA
11/2018 - 01/2009
7Coloring Agents (Dyes)IBA
10/2021 - 11/2011
7LigandsIBA
10/2021 - 03/2009
6Fluorescent Dyes (Fluorescent Probes)IBA
01/2019 - 08/2008
5AntibodiesIBA
10/2021 - 01/2009
5Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2008
5Trastuzumab (Herceptin)FDA Link
05/2010 - 03/2009
4silicon phthalocyanineIBA
10/2021 - 11/2018
4Photosensitizing Agents (Photosensitizers)IBA
02/2021 - 11/2011
4Liposomes (Liposome)IBA
01/2020 - 01/2014
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2013 - 05/2004
4AvidinIBA
05/2010 - 01/2009
4Galactose (Galactopyranose)FDA LinkGeneric
02/2010 - 08/2008
3Therapeutic UsesIBA
10/2021 - 11/2006
3CollagenIBA
07/2020 - 10/2008
3Glucose (Dextrose)FDA LinkGeneric
03/2020 - 02/2010
3Pharmaceutical PreparationsIBA
02/2020 - 03/2013
3Dendrimers (Dendrons)IBA
11/2015 - 06/2009
3Contrast MediaIBA
11/2014 - 06/2009
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2014 - 11/2006
3RhodaminesIBA
11/2011 - 08/2008
2fluoromisonidazoleIBA
05/2022 - 05/2019
2Apolipoproteins E (ApoE)IBA
11/2021 - 01/2019
2HexokinaseIBA
03/2020 - 08/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 03/2013
2PhosphatidylserinesIBA
01/2019 - 03/2015
2Immunoglobulin G (IgG)IBA
01/2017 - 10/2008
2Peptides (Polypeptides)IBA
09/2016 - 01/2003
2Gefitinib (Iressa)FDA Link
09/2016 - 01/2013
2Pentetic Acid (DTPA)FDA LinkGeneric
12/2014 - 11/2014
2PolymersIBA
12/2014 - 03/2013
2Tumor Biomarkers (Tumor Markers)IBA
10/2013 - 01/2009
2Cholinergic Agents (Cholinergics)IBA
10/2013 - 02/2006
2ErbB Receptors (EGF Receptor)IBA
01/2013 - 11/2011
2Indicators and Reagents (Reagents)IBA
12/2009 - 08/2008
2Cell Surface ReceptorsIBA
10/2008 - 11/2007
2oxidized low density lipoproteinIBA
10/2008 - 11/2007
1Singlet OxygenIBA
11/2021
1ApolipoproteinsIBA
11/2021
1AntigensIBA
10/2021
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2021
1Biological ProductsIBA
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021
1Transforming Growth Factor beta (TGF-beta)IBA
07/2020
1cyclic guanosine monophosphate-adenosine monophosphateIBA
03/2020
1Adenosine Monophosphate (AMP)IBA
03/2020
1Immune Checkpoint InhibitorsIBA
03/2020
1AnionsIBA
01/2020
1Drug CarriersIBA
01/2020
1phosphatidylserine receptorIBA
01/2019
1Glutathione (Reduced Glutathione)IBA
01/2019
1NitroimidazolesIBA
01/2019
1EnzymesIBA
01/2019
1pimonidazoleIBA
01/2019
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2018
1SolutionsIBA
04/2018
1Cathepsin BIBA
09/2016
1NucleophosminIBA
09/2016
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
09/2016
1Ribosomal RNAIBA
09/2016
1polyarginineIBA
09/2016
1Carbon-11IBA
05/2015
1PK 11195 (PK11195)IBA
05/2015
1Oxidopamine (6 Hydroxydopamine)IBA
05/2015
1GalactosidasesIBA
03/2015
1Prostaglandins AIBA
11/2014
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
11/2014
1GD3 ganglioside (GD(3))IBA
11/2014

Therapy/Procedure

16Therapeutics
05/2022 - 11/2006
3Immunotherapy
05/2022 - 02/2020
3Phototherapy (Light Therapy)
11/2021 - 09/2018
2Catheters
02/2021 - 09/2004
2Photochemotherapy (Photodynamic Therapy)
08/2013 - 11/2011
2Drug Therapy (Chemotherapy)
03/2013 - 11/2011
1Aftercare (After-Treatment)
10/2021
1Intravenous Injections
11/2014